Neuropeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $6K

  • Investors
  • 9

Neuropeutics General Information

Description

Operator of a pharmaceutical company designed to develop targeted therapies to treat neurodegenerative diseases. The company offers treatments that slow disease progression, develops small-molecule and related drug candidates directed at specific pathways in the nervous system, and applies preclinical research methods to assess efficacy and safety, enabling patients to receive effective care, survive, and improve their quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 60 Leonard Avenue
  • Room 4KD-481
  • Toronto, Ontario M5T 0S8
  • Canada
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 60 Leonard Avenue
  • Room 4KD-481
  • Toronto, Ontario M5T 0S8
  • Canada

Neuropeutics Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neuropeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Accelerator/Incubator 12-Jun-2026 $6K Completed Pre-Clinical Trials
9. Accelerator/Incubator 28-Nov-2025 Completed Pre-Clinical Trials
8. Grant 16-Sep-2025 Completed Pre-Clinical Trials
7. Grant 30-Oct-2024 Completed Pre-Clinical Trials
6. Accelerator/Incubator 01-May-2024 Completed Pre-Clinical Trials
5. Grant 12-Mar-2024 Completed Pre-Clinical Trials
4. Accelerator/Incubator Completed Pre-Clinical Trials
3. Accelerator/Incubator 29-Sep-2023 Completed Pre-Clinical Trials
2. Accelerator/Incubator 06-Sep-2023 $15K Completed Pre-Clinical Trials
1. Accelerator/Incubator 06-Jun-2023 $15K $15K Completed Pre-Clinical Trials
To view Neuropeutics’s complete valuation and funding history, request access »

Neuropeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neuropeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
IDEA Mississauga Accelerator/Incubator
CABHI Corporate Venture Capital
Ontario Brain Institute Accelerator/Incubator
University of Toronto University Minority
University of Toronto Entrepreneurship Accelerator/Incubator
You’re viewing 5 of 9 investors. Get the full list »

Neuropeutics FAQs

  • When was Neuropeutics founded?

    Neuropeutics was founded in 2023.

  • Where is Neuropeutics headquartered?

    Neuropeutics is headquartered in Toronto, Canada.

  • What is the size of Neuropeutics?

    Neuropeutics has 6 total employees.

  • What industry is Neuropeutics in?

    Neuropeutics’s primary industry is Drug Discovery.

  • Is Neuropeutics a private or public company?

    Neuropeutics is a Private company.

  • What is Neuropeutics’s current revenue?

    The current revenue for Neuropeutics is .

  • How much funding has Neuropeutics raised over time?

    Neuropeutics has raised $41K.

  • Who are Neuropeutics’s investors?

    IDEA Mississauga, CABHI, Ontario Brain Institute, University of Toronto, and University of Toronto Entrepreneurship are 5 of 9 investors who have invested in Neuropeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process